CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 4,052,231 enrolled
Drug / intervention
No interventionother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05727306
NCT05727306N/ACompleted

Healthcare Disparities in Alopecia Areata: UK Population-based Cohort Study

Momentum Data·observational·Posted Feb 14, 2023·Updated Jun 18, 2025

In Brief

An observational study evaluating No intervention for Alopecia Areata. Completed, enrolled 4,052,231 participants across 1 site.

Detailed Summary

Alopecia areata (AA) is a common immune-mediated non-scarring alopecia often associated with substantial morbidity. There are however, limited population-based data on potential disparities in the burden of AA, including across people of different ethnicities and deprivation. We aimed to provide the first large-scale, population-based estimate of lifetime risk of AA overall and by important sociodemographic subgroups. As AA is associated with an increased burden of mental health conditions and work-related outcomes (unemployment, time off work), a detailed understanding of the burden of disease in different sociodemographic groups is vital to plan resource provision.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAlopecia Areata
CountriesUnited Kingdom

Timeline

N/ACompletedFinished
2023202420252026
First PostedFeb 14, 2023
Enrollment StartOct 1, 2022
Primary CompletionJul 24, 2024
Study CompletionAug 6, 2024
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 3.4 years ago

Interventions

No interventionother

Observational analysis of usual care only.